CME: CME has excellent market share and room to run!

CME is a great company and exchange (trading there for over 12 years, proud shareholder for 2). Their recently announced, pending acquisition of the NYMEX will bring stability and growth to their product line and earnings. CME has, with the acquisition of the CBOT, a large presence in the futures trading arena, and is excelling to compete with other global exchanges such as the LIFFE and ICE. Earnings are also due out on CME on Tuesday, and have a consensus of $3.62 versus prior year of $2.91. My outlook is for $3.90 earnings and a solid outlook for the year to come for the exchange.